ArticleACS chemical neuroscience2014
Synthesis and imaging validation of [¹⁸F]MDL100907 enabled by Ni-mediated fluorination.
Article in ACS chemical neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 60 citations in OpenAlex.
- Triarylselenonium triflates provide efficient access to no-carrier-addedChemical science · 2026Article
- Copper-mediated radiochemistry: historical impact, current trends, and future possibilities.Npj imaging · 2025Review
- One-Step Synthesis of [ACS central science · 2024Article
- Concise and Scalable Radiosynthesis of (+)-[ACS chemical neuroscience · 2023Article
- Automated synthesis of (R)-[Journal of labelled compounds & radiopharmaceuticals · 2022Article
- Radiotracers for the Central Serotoninergic System.Pharmaceuticals (Basel, Switzerland) · 2022Review
- Radiosynthesis and Biological Evaluation of [ACS medicinal chemistry letters · 2021Article
- Sequential Ir/Cu-Mediated Method for theJournal of the American Chemical Society · 2021Article
- Site-Selective Late-Stage Aromatic [Angewandte Chemie (International ed. in English) · 2020Article
- Radiosynthesis of the norepinephrine transporter tracer [Journal of labelled compounds & radiopharmaceuticals · 2019Article
- An azeotropic drying-free approach for copper-mediated radiofluorination without addition of base.Journal of labelled compounds & radiopharmaceuticals · 2019Article
- Chemistry for Positron Emission Tomography: Recent Advances inAngewandte Chemie (International ed. in English) · 2019Review
- Optimization ofJournal of labelled compounds & radiopharmaceuticals · 2018Article
- Synthesis of [Angewandte Chemie (International ed. in English) · 2017Article
- Article
- Fluorine-18 patents (2009-2015). Part 2: new radiochemistry.Pharmaceutical patent analyst · 2016Review
- Development of a Fluorinated Class-I HDAC Radiotracer Reveals Key Chemical Determinants of Brain Penetrance.ACS chemical neuroscience · 2016Article
- A Transmetalation Reaction Enables the Synthesis of [Organometallics · 2016Article
- Moving Metal-Mediated (18)F-Fluorination from Concept to Clinic.ACS central science · 2016Article
- Synthesis of [18F]Arenes via the Copper-Mediated [18F]Fluorination of Boronic Acids.Organic letters · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
Abstract
Several voids exist in reliable positron emission tomography (PET) radioligands for quantification of the serotonin (5HT) receptor system. Even in cases where 5HT radiotracers exist, challenges remain that have limited the utility of 5HT imaging in clinical research. Herein we address an unmet need in 5HT2a imaging using innovative chemistry. We report a scalable and robust synthesis of [(18)F]MDL100907, which was enabled by a Ni-mediated oxidative fluorination using [(18)F]fluoride. This first demonstration of a Ni-mediated fluorination used for PET imaging required development of a new reaction strategy that ultimately provided high specific activity [(18)F]MDL100907. Using the new synthetic strategy and optimized procedure, [(18)F]MDL100907 was evaluated against [(11)C]MDL100907 for reliability to quantify 5HT₂a in the nonhuman primate brain and was found to be superior based on a single scan analysis using the same nonhuman primate. The use of this new 5HT₂a radiotracer will afford clinical neuroscience research the ability to distinguish 5HT₂a receptor abnormalities binding between healthy subjects and patients even when group differences are small.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.